Quantitative determination of butorphanol and its metabolites in human plasma by gas chromatography-electron capture negative-ion chemical ionization mass spectrometry
スポンサーリンク
概要
- 論文の詳細を見る
- 1996-07-12
著者
-
DUNCAN Glenn
Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Company
-
BARBHAIYA Rashmi
Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Company
-
Tay Lee
Department Of Metabolism And Pharmacokinetics Pharmaceutical Research Institute
-
Duncan Glenn
Department Of Metabolism And Pharmacokinetics Pharmaceutical Research Institute
-
Duncan Glenn
Department Of Metabolism And Pharmacokinetics Bristol-myers Squibb Company
-
MULVANA Daniel
Department of Metabolism and Pharmacokinetics, Pharmaceutical Research Institute
-
SHYU Wen
Department of Metabolism and Pharmacokinetics, Pharmaceutical Research Institute
-
Shyu Wen
Department Of Metabolism And Pharmacokinetics Pharmaceutical Research Institute
-
Shyu Wen
Department Of Metabolism And Pharmacokinetics Bristol-myers Squibb Pharmaceutical Research Institute
-
Mulvana Daniel
Department Of Metabolism And Pharmacokinetics Pharmaceutical Research Institute
-
Barbhaiya Rashmi
Department Of Metabolism And Pharmacokinetics Pharmaceutical Research Institute
-
Barbhaiya Rashmi
Department Of Metabolism And Pharmacokinetics Bristol-myers Squibb Company
関連論文
- Determination of a novel indolylpiperazine anti-migraine agent in rat, monkey, mouse and rabbit plasma by high-performance liquid chromatography with electrochemical detection
- Quantitative determination of butorphanol and its metabolites in human plasma by gas chromatography-electron capture negative-ion chemical ionization mass spectrometry
- Sensitive liquid chromatographic-mass spectrometric assay for the simultaneous quantitation of nefazodone and its metabolites hydroxynefazodone m-chlorophenylpiperazine and triazole-dione in human plasma using single-ion monitoring